These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33153966)

  • 1. Circulating magnesium status is associated with type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a long-term cohort study.
    Haenni A; Nilsen I
    Surg Obes Relat Dis; 2021 Feb; 17(2):299-307. PubMed ID: 33153966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased circulating magnesium concentrations after Roux-en-Y gastric bypass surgery in patients with type 2 diabetes.
    Haenni A; Nilsen I; Johansson HE
    Surg Obes Relat Dis; 2018 May; 14(5):576-582. PubMed ID: 29567058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleeve gastrectomy and Roux-en-Y gastric bypass in the treatment of type 2 diabetes. Two-year results from a Swedish multicenter randomized controlled trial.
    Wallenius V; Alaraj A; Björnfot N; Orrenius B; Kylebäck A; Björklund P; Werling M; Thorell A; Fändriks L; Maleckas A
    Surg Obes Relat Dis; 2020 Aug; 16(8):1035-1044. PubMed ID: 32540150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 diabetes remission after Roux-en-Y gastric bypass: a multicentered experience with long-term follow-up.
    Hage K; Ikemiya K; Ghusn W; Lu L; Kennel KA; McKenzie TJ; Kellogg TA; Abu Dayyeh BK; Higa KD; Spaniolas K; Ma P; Ghanem OM
    Surg Obes Relat Dis; 2023 Dec; 19(12):1339-1345. PubMed ID: 37914608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 Diabetes Remission in Patients with Heterozygous Variants in the Leptin-Melanocortin Pathway after Roux-en-Y Gastric Bypass: A Matched Case-Control Study.
    Anazco D; Ghusn W; Campos A; Cifuentes L; Fansa S; Tama E; Bublitz JT; Gala K; Hurtado MD; Olson JE; Acosta A
    Obes Surg; 2023 Nov; 33(11):3502-3509. PubMed ID: 37798511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Yan Y; Sha Y; Yao G; Wang S; Kong F; Liu H; Zhang G; Zhang H; Hu C; Zhang X
    Medicine (Baltimore); 2016 Apr; 95(17):e3462. PubMed ID: 27124041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Gastric Bypass with a Distal Gastric Pouch on Glucose Tolerance and Diabetes Remission in Type 2 Diabetes Sprague-Dawley Rat Model.
    Dolo PR; Shao Y; Li C; Zhu X; Yao L; Wang H
    Obes Surg; 2019 Jun; 29(6):1889-1900. PubMed ID: 30778846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Changes in Gut Microbiota After Gastric Bypass and Sleeve Gastrectomy Bariatric Surgery Vary According to Diabetes Remission.
    Murphy R; Tsai P; Jüllig M; Liu A; Plank L; Booth M
    Obes Surg; 2017 Apr; 27(4):917-925. PubMed ID: 27738970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Health in Patients with Type 2 Diabetes Treated by Roux-En-Y Gastric Bypass and the Role of Diabetes Remission.
    Madsen LR; Espersen R; Ornstrup MJ; Jørgensen NR; Langdahl BL; Richelsen B
    Obes Surg; 2019 Jun; 29(6):1823-1831. PubMed ID: 30719648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population-based matched cohort study.
    Madsen LR; Baggesen LM; Richelsen B; Thomsen RW
    Diabetologia; 2019 Apr; 62(4):611-620. PubMed ID: 30734055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of bariatric surgery on insulin-treated type 2 diabetes patients.
    Lemus R; Karni D; Hong D; Gmora S; Breau R; Anvari M
    Surg Endosc; 2018 Feb; 32(2):990-1001. PubMed ID: 28842774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative use of incretins is associated with increased diabetes remission after RYGB surgery among patients taking insulin: a retrospective cohort analysis.
    Wood GC; Gerhard GS; Benotti P; Petrick AT; Gabrielsen JD; Strodel WE; Ibele A; Rolston DD; Still CD; Argyropoulos G
    Ann Surg; 2015 Jan; 261(1):125-8. PubMed ID: 24646545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should Roux-en-Y gastric bypass biliopancreatic limb length be tailored to achieve improved diabetes outcomes?
    Nora M; Morais T; Almeida R; Guimarães M; Monteiro MP
    Medicine (Baltimore); 2017 Dec; 96(48):e8859. PubMed ID: 29310367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors determining chance of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a nationwide cohort study in 8057 Swedish patients.
    Stenberg E; Olbers T; Cao Y; Sundbom M; Jans A; Ottosson J; Naslund E; Näslund I
    BMJ Open Diabetes Res Care; 2021 May; 9(1):. PubMed ID: 33990366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bariatric procedure selection in patients with type 2 diabetes: choice between Roux-en-Y gastric bypass or sleeve gastrectomy.
    Aminian A
    Surg Obes Relat Dis; 2020 Feb; 16(2):332-339. PubMed ID: 31902579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Mediating Type 2 Diabetes Remission and Relapse after Gastric Bypass Surgery.
    Pessoa BM; Browning MG; Mazzini GS; Wolfe L; Kaplan A; Khoraki J; Campos GM
    J Am Coll Surg; 2020 Jan; 230(1):7-16. PubMed ID: 31672669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Weight Loss Results, Remission of Comorbidities and Nutritional Deficiencies of Sleeve Gastrectomy (SG), Roux-En-Y Gastric Bypass (RYGB) and One-Anastomosis Gastric Bypass (OAGB) on Type 2 Diabetic (T2D) Patients.
    Castro MJ; Jimenez JM; Carbajo MA; Lopez M; Cao MJ; Garcia S; Ruiz-Tovar J
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33092117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery for type 2 diabetes: the case for Roux-en-Y gastric bypass.
    Spaniolas K; Pories WJ
    Surg Obes Relat Dis; 2016 Jul; 12(6):1220-4. PubMed ID: 27260652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roux-en-Y gastric bypass for nonobese patients with uncontrolled type 2 diabetes: a long-term evaluation.
    Ferraz ÁAB; de Sá VCT; Santa-Cruz F; Siqueira LT; Silva LB; Campos JM
    Surg Obes Relat Dis; 2019 May; 15(5):682-687. PubMed ID: 31005458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roux-en-Y Gastric Bypass for T2D Treatment in Chinese Patients with Low BMI: 5-Year Outcomes.
    Wang C; Zhang H; Yu H; Bao Y; Zhang P; Di J
    Obes Surg; 2020 Jul; 30(7):2588-2597. PubMed ID: 32157522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.